Fig. 3.
Fig. 3. Expression profile of hCD4 in hematopoietic tissues of HS21/45 vav-hCD4 progeny mice. Nucleated bone marrow (A) B220+, (B) IgM+, and (C) IgD+B-lymphoid cells; (D) Mac1+ myeloid cells; (E) Ter119+ erythroid cells; and splenic (F) Thy1+ T cells. Quadrants were set so that the marker+ hCD4+ cells in a nontransgenic control sample, run in parallel, did not exceed 5% of total marker+ cells analyzed. As would be expected, essentially all cells from the nontransgenic controls then fell in the left quadrants, and the percentage of cells bearing each lineage-specific marker (eg, B220) was similar to that of the corresponding transgenic population.

Expression profile of hCD4 in hematopoietic tissues of HS21/45 vav-hCD4 progeny mice. Nucleated bone marrow (A) B220+, (B) IgM+, and (C) IgD+B-lymphoid cells; (D) Mac1+ myeloid cells; (E) Ter119+ erythroid cells; and splenic (F) Thy1+ T cells. Quadrants were set so that the marker+ hCD4+ cells in a nontransgenic control sample, run in parallel, did not exceed 5% of total marker+ cells analyzed. As would be expected, essentially all cells from the nontransgenic controls then fell in the left quadrants, and the percentage of cells bearing each lineage-specific marker (eg, B220) was similar to that of the corresponding transgenic population.

Close Modal

or Create an Account

Close Modal
Close Modal